122 related articles for article (PubMed ID: 7562358)
1. Occurrence of Actinobacillus actinomycetemcomitans and anti-leukotoxin antibodies in some members of an extended family affected by Papillon-Lefèvre syndrome.
Stabholz A; Taichman NS; Soskolne WA
J Periodontol; 1995 Jul; 66(7):653-7. PubMed ID: 7562358
[TBL] [Abstract][Full Text] [Related]
2. Clinical, bacteriological, and immunological examinations and the treatment process of two Papillon-Lefèvre syndrome patients.
Ishikawa I; Umeda M; Laosrisin N
J Periodontol; 1994 Apr; 65(4):364-71. PubMed ID: 8195982
[TBL] [Abstract][Full Text] [Related]
3. Periodontal therapy in siblings with Papillon-Lefèvre syndrome and tinea capitis: a report of two cases.
Schacher B; Baron F; Ludwig B; Valesky E; Noack B; Eickholz P
J Clin Periodontol; 2006 Nov; 33(11):829-36. PubMed ID: 16970621
[TBL] [Abstract][Full Text] [Related]
4. Combined mechanical and antibiotic periodontal therapy in a case of Papillon-Lefèvre syndrome.
Eickholz P; Kugel B; Pohl S; Näher H; Staehle HJ
J Periodontol; 2001 Apr; 72(4):542-9. PubMed ID: 11338309
[TBL] [Abstract][Full Text] [Related]
5. The prevalence of Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, and Bacteroides forsythus in humans 1 year after 4 randomized treatment modalities.
Shiloah J; Patters MR; Dean JW; Bland P; Toledo G
J Periodontol; 1998 Dec; 69(12):1364-72. PubMed ID: 9926766
[TBL] [Abstract][Full Text] [Related]
6. Molecular mimicry of Aggregatibacter actinomycetemcomitans with beta2 glycoprotein I.
Wang D; Nagasawa T; Chen Y; Ushida Y; Kobayashi H; Takeuchi Y; Umeda M; Izumi Y
Oral Microbiol Immunol; 2008 Oct; 23(5):401-5. PubMed ID: 18793363
[TBL] [Abstract][Full Text] [Related]
7. Papillon-Lefèvre syndrome: serum immunoglobulin G (IgG) subclass antibody response to periodontopathic bacteria. A case report.
Wara-aswapati N; Lertsirivorakul J; Nagasawa T; Kawashima Y; Ishikawa I
J Periodontol; 2001 Dec; 72(12):1747-54. PubMed ID: 11811512
[TBL] [Abstract][Full Text] [Related]
8. The immunoreactivity of systemic antibodies to Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in adult periodontitis.
Johansson A; Buhlin K; Koski R; Gustafsson A
Eur J Oral Sci; 2005 Jun; 113(3):197-202. PubMed ID: 15953243
[TBL] [Abstract][Full Text] [Related]
9. Occurrence of Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, and Prevotella intermedia in progressive adult periodontitis.
López NJ
J Periodontol; 2000 Jun; 71(6):948-54. PubMed ID: 10914798
[TBL] [Abstract][Full Text] [Related]
10. The subgingival microbiota of Papillon-Lefèvre syndrome.
Albandar JM; Khattab R; Monem F; Barbuto SM; Paster BJ
J Periodontol; 2012 Jul; 83(7):902-8. PubMed ID: 22141356
[TBL] [Abstract][Full Text] [Related]
11. Humoral immune response to Aggregatibacter actinomycetemcomitans leukotoxin.
Brage M; Holmlund A; Johansson A
J Periodontal Res; 2011 Apr; 46(2):170-5. PubMed ID: 21118415
[TBL] [Abstract][Full Text] [Related]
12. Periodontal debridement as a therapeutic approach for severe chronic periodontitis: a clinical, microbiological and immunological study.
Del Peloso Ribeiro E; Bittencourt S; Sallum EA; Nociti FH; Gonçalves RB; Casati MZ
J Clin Periodontol; 2008 Sep; 35(9):789-98. PubMed ID: 18647203
[TBL] [Abstract][Full Text] [Related]
13. Clinical responses to mechanical periodontal treatment in Chinese chronic periodontitis patients with and without Actinobacillus actinomycetemcomitans.
Tong KS; Zee KY; Lee DH; Corbet EF
J Periodontol; 2003 Nov; 74(11):1582-8. PubMed ID: 14682654
[TBL] [Abstract][Full Text] [Related]
14. Presence of Aggregatibacter actinomycetemcomitans in young individuals: a 16-year clinical and microbiological follow-up study.
Aberg CH; Sjödin B; Lakio L; Pussinen PJ; Johansson A; Claesson R
J Clin Periodontol; 2009 Oct; 36(10):815-22. PubMed ID: 19678862
[TBL] [Abstract][Full Text] [Related]
15. Combined systemic and local antimicrobial therapy of periodontal disease in Papillon-Lefèvre syndrome. A report of 4 cases.
Rüdiger S; Petersilka G; Flemmig TF
J Clin Periodontol; 1999 Dec; 26(12):847-54. PubMed ID: 10599914
[TBL] [Abstract][Full Text] [Related]
16. Actinobacillus actinomycetemcomitans in destructive periodontal disease. Three-year follow-up results.
Buchmann R; Müller RF; Heinecke A; Lange DE
J Periodontol; 2000 Mar; 71(3):444-53. PubMed ID: 10776933
[TBL] [Abstract][Full Text] [Related]
17. Periodontal findings and systemic antibody responses to oral microorganisms in Behçet's disease.
Celenligil-Nazliel H; Kansu E; Ebersole JL
J Periodontol; 1999 Dec; 70(12):1449-56. PubMed ID: 10632520
[TBL] [Abstract][Full Text] [Related]
18. Microbiological and immunological characteristics of young Moroccan patients with aggressive periodontitis with and without detectable Aggregatibacter actinomycetemcomitans JP2 infection.
Rylev M; Bek-Thomsen M; Reinholdt J; Ennibi OK; Kilian M
Mol Oral Microbiol; 2011 Feb; 26(1):35-51. PubMed ID: 21214871
[TBL] [Abstract][Full Text] [Related]
19. Actinobacillus actinomycetemcomitans and localized juvenile periodontitis. Clinical, microbiologic and histologic studies.
Christersson LA
Swed Dent J Suppl; 1993; 90():1-46. PubMed ID: 8236029
[TBL] [Abstract][Full Text] [Related]
20. Orthodontic treatment in a patient with Papillon-Lefèvre syndrome.
Lux CJ; Kugel B; Komposch G; Pohl S; Eickholz P
J Periodontol; 2005 Apr; 76(4):642-50. PubMed ID: 15857107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
